AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Intro
This chapter reviews findings from the ACR Convergence 2024 regarding the comparative risks of tofacitinib and adalumab for rheumatoid arthritis treatment. It emphasizes the significance of statin use and optimizing baseline therapy to manage associated cardiovascular risks.